Duopharma gets extension for supply of insulin products


  • Corporate News
  • Monday, 02 Dec 2019

Duopharma said on Monday the government had written to Biocon Sdn Bhd and the company about the amendments to the January 2017 agreement which included an extension to supply the insulin.

KUALA LUMPUR: Duopharma Biotech Bhd had its contract to supply human insulin product to the government extended by one year to Dec 1,2020 with an additional contract value of RM91.06mil.

It said on Monday the government had written to Biocon Sdn Bhd and the company about the amendments to the January 2017 agreement which included an extension to supply the insulin.

This is under the Health Ministry's offtake agreement programme.

Biocon is the manufacturer and its unit Duopharma Marketing Sdn Bhd is Biocon’s authorised distributor/ reseller.


Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 7
Cxense type: free
User access status: 3
   

Across The Star Online